Nations Financial Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-662
Closed -$232K 783
2025
Q4
$232K Buy
662
+10
+2% +$3.38K 0.01% 679
2025
Q3
$211K Sell
652
-72
-10% -$22.4K 0.01% 670
2025
Q2
$282K Sell
724
-30
-4% -$12.1K 0.02% 577
2025
Q1
$328K Buy
754
+1
+0.1% +$401 0.03% 517
2024
Q4
$278K Sell
753
-12
-2% -$5.02K 0.02% 567
2024
Q3
$398K Buy
765
+3
+0.4% +$1.6K 0.03% 497
2024
Q2
$413K Hold
762
0.03% 459
2024
Q1
$395K Sell
762
-334
-30% -$166K 0.03% 480
2023
Q4
$517K Buy
1,096
+6
+0.6% +$2.77K 0.05% 384
2023
Q3
$475K Buy
+1,090
New +$494K 0.05% 379
2023
Q1
Sell
-2,972
Closed -$1.52M 621
2022
Q4
$1.52M Buy
+2,972
New +$1.51M 0.17% 153

Other funds holding ELV

Nations Financial Group's ELV Position: Q1 2026 in Review

Nations Financial Group sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 662 shares — an estimated $232K sold.

Nations Financial Group first reported a position in ELV in Q4 2022 and held it in 11 quarters. The position peaked at $1.52M in Q4 2022. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Nations Financial Group reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
  • Nations Financial Group sold 662 Elevance Health shares in Q1 2026, an estimated $232K.
  • Nations Financial Group first reported a position in Elevance Health in Q4 2022 and held it in 11 quarters.
  • Nations Financial Group's Elevance Health position peaked at $1.52M in Q4 2022.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Nations Financial Group's 13F filing for Q1 2026, filed 15 Apr 2026.